Two chronic pain treatments based on cognitive behavioral therapy (CBT) — telehealth coaching and online self-completed pain coping skills training — improved pain severity and quality of life compared to usual care in patients with high-impact chronic pain, according to a recent study published in JAMA.
A cardiovascular disease risk prediction tool developed by Northwestern Medicine scientists may also be effective for identifying which patients most benefit from statin therapy, according to a recent study published in JAMA Cardiology.
Scientists have discovered more than 100 new epigenetic biomarkers that may help predict cardiovascular disease risk and inform preventive care measures to improve long-term outcomes, according to a recent study published in Circulation.
Northwestern scientists have discovered that the organization of a cell’s genetic material dictates cancer’s ability to adapt, according to a recent study published in the Proceedings of the National Academy of Sciences.
A new wireless and wearable device developed by Northwestern Medicine scientists measures specific biomarkers in a person’s sweat and has the potential to improve clinical decision-making for cystic fibrosis, as detailed in a recent study published in the Proceedings of the National Academy of Sciences.
A novel drug may significantly improve outcomes for a subset of patients with high blood pressure, according to findings published in The New England Journal of Medicine.
A genetic mismatch may influence kidney transplant success and could inform how donor-recipient compatibility is assessed, according to a study published in Science Translational Medicine.
Over a quarter-century of research, Northwestern scientists have been studying individuals over eighty with memory capacity of people at least three decades younger, to identify the biological and behavioral traits associated with “SuperAging.”
A multi-center study has identified critical risk factors that increase the likelihood of death in children with Fontan circulatory failure who are awaiting or have recently undergone heart transplantation, according to findings published in Circulation.
A drug already FDA-approved for asthma was found to nearly eliminate life-threatening allergic reactions to food allergens in mice, according to a new Northwestern Medicine study published in the journal Science.
Notifications